Liabilities and Equity of NeuroSense Therapeutics Ltd. from 31 Dec 2022 to 30 Jun 2025

Taxonomy & unit: us-gaap: USD
Description: Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.
Summary: NeuroSense Therapeutics Ltd. quarterly Liabilities and Equity in USD history and change rate from 31 Dec 2022 to 30 Jun 2025.
NeuroSense Therapeutics Ltd. Liabilities and Equity for the quarter ending 30 Jun 2025 was $1,684,000, a 8.5% decline year-over-year.
Source SEC data: View on sec.gov

Liabilities and Equity, Quarterly (USD)

Liabilities and Equity, YoY Quarterly Change (%)

NeuroSense Therapeutics Ltd. Quarterly Liabilities and Equity (USD)

Period	Value	YoY Chg	Change %	Date	Report	Filed	Fiscal Year	Fiscal Period
Q2 2025	$1,684,000	-$157,000	-8.5%	30 Jun 2025	6-K	01 Aug 2025	2025	Q2
Q4 2024	$4,575,000	+$1,390,000	+44%	31 Dec 2024	6-K	01 Aug 2025	2025	Q2
Q2 2024	$1,841,000			30 Jun 2024	6-K	30 Sep 2024	2024	Q2
Q4 2023	$3,185,000	-$4,532,000	-59%	31 Dec 2023	20-F	07 Apr 2025	2024	FY
Q4 2022	$7,717,000			31 Dec 2022	6-K	17 Jun 2024	2023	FY

* An asterisk sign (*) next to the value indicates that the value is likely invalid.